Enhabit, Inc. (NYSE:EHAB) Short Interest Update

Enhabit, Inc. (NYSE:EHAB) was the target of a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 1,220,000 shares, a decrease of 5.4% from the December 15th total of 1,290,000 shares. Currently, 2.8% of the shares of the company are short sold. Based on an average trading volume of 375,300 shares, the short-interest ratio is currently 3.3 days.

Enhabit Trading Up 0.2 %

Shares of EHAB stock opened at $7.99 on Friday. The company has a market cap of $401.52 million, a P/E ratio of -3.44 and a beta of 1.82. The stock has a 50 day simple moving average of $7.83 and a two-hundred day simple moving average of $8.11. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. Enhabit has a fifty-two week low of $6.85 and a fifty-two week high of $11.74.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). The firm had revenue of $253.60 million for the quarter, compared to the consensus estimate of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same quarter in the prior year, the firm earned $0.03 EPS. Research analysts forecast that Enhabit will post 0.22 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have recently commented on EHAB. Jefferies Financial Group raised Enhabit from a “hold” rating to a “buy” rating and lifted their price target for the company from $8.25 to $9.50 in a research note on Monday, December 9th. Leerink Partners reissued a “market perform” rating and set a $8.00 price target (down from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $8.75.

Insider Activity at Enhabit

In related news, Director Jeffrey Bolton bought 4,000 shares of Enhabit stock in a transaction dated Thursday, December 12th. The shares were bought at an average cost of $8.69 per share, with a total value of $34,760.00. Following the acquisition, the director now owns 98,144 shares in the company, valued at $852,871.36. This trade represents a 4.25 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Stuart M. Mcguigan bought 15,000 shares of Enhabit stock in a transaction dated Tuesday, December 10th. The shares were bought at an average cost of $8.81 per share, for a total transaction of $132,150.00. Following the completion of the acquisition, the director now owns 46,810 shares in the company, valued at $412,396.10. This represents a 47.15 % increase in their position. The disclosure for this purchase can be found here. 1.90% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of EHAB. JPMorgan Chase & Co. boosted its position in Enhabit by 37.8% in the third quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company’s stock worth $2,411,000 after purchasing an additional 83,707 shares during the last quarter. Franklin Resources Inc. boosted its position in Enhabit by 19.6% in the third quarter. Franklin Resources Inc. now owns 32,382 shares of the company’s stock worth $256,000 after purchasing an additional 5,317 shares during the last quarter. Geode Capital Management LLC boosted its position in Enhabit by 0.9% in the third quarter. Geode Capital Management LLC now owns 1,137,458 shares of the company’s stock worth $8,987,000 after purchasing an additional 10,538 shares during the last quarter. Y Intercept Hong Kong Ltd purchased a new position in Enhabit in the third quarter worth $450,000. Finally, XTX Topco Ltd purchased a new position in Enhabit in the third quarter worth $123,000.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.